(Reuters) – Europe’s drug regulator said on Wednesday it had assessed nine cases of an auto-immune blood condition following vaccination with Moderna Inc’s COVID-19 shot, but no “clear causal relationship” could be established between the two.
The European Medicines Agency (EMA) said its safety committee would continue to monitor for cases of immune thrombocytopenia, an auto-immune condition with low blood platelet levels that can lead to bruising and bleeding, with Moderna’s vaccine, Spikevax.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Rashmi Aich)
